Fig. 6From: Differences in genetics and microenvironment of lung adenocarcinoma patients with or without TP53 mutationExpression of immune modulators (*represents P < 0.05, ** represents P < 0.01, ***represents P < 0.001). Relative expression level of immune co-inhibitors (A) and co-stimulators (B)Back to article page